Search Results - "Medina, Diego Márquez"
-
1
Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion
Published in Cirugia española (English ed.) (01-11-2022)“…This article summarizes the clinical guidelines for the diagnosis and treatment of malignant pleural effusion (MPE) sponsored by the Spanish Society of…”
Get full text
Journal Article -
2
Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer
Published in Lung cancer (Amsterdam, Netherlands) (01-09-2013)“…Abstract Objectives The aim was to determine if combined pemetrexed, cisplatin, and cetuximab was efficacious and safe as first-line treatment in advanced…”
Get full text
Journal Article -
3
Pleural epithelioid hemangioendothelioma in an elderly patient. A case report and review of the literature
Published in Lung cancer (Amsterdam, Netherlands) (01-07-2011)“…Abstract Pleural epithelioid hemangioendothelioma is a really rare tumor of vascular origin and potentially aggressive behavior. We report the case of an 85…”
Get full text
Journal Article -
4
Opening Windows for Thymic Tumors
Published in Journal of thoracic oncology (01-02-2023)Get more information
Journal Article -
5
Are the neuropsychological alterations in eating disorders endophenotypes of the disease? Review and state of the art
Published in Revista de neurologiá (16-12-2012)“…INTRODUCTION. Recent studies have shown that alterations to the executive cognitive functions may be endophenotypes of eating disorders. AIM. To perform a…”
Get full text
Journal Article -
6
Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer
Published in Future oncology (London, England) (01-09-2015)“…First-generation reversible EGF receptor (EGFR) tyrosine kinase inhibitors (TKIs) changed our understanding of advanced non-small-cell lung cancer biology and…”
Get full text
Journal Article -
7
Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC
Published in Journal of thoracic oncology (01-05-2018)Get more information
Journal Article -
8
-
9
Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib
Published in Archivos de bronconeumología (English ed.) (01-02-2013)“…It has been suggested that human papillomavirus (HPV) could participate in the development of non-small-cell lung cancer (NSCLC). A higher HPV infection rate…”
Get full text
Journal Article -
10
Systemic therapy for pulmonary carcinoids
Published in Lung cancer (Amsterdam, Netherlands) (01-11-2015)“…Highlights • We review the systemic treatment for pulmonary carcinoids. • Data are limited and biases are common. Well-designed prospective randomized trials…”
Get full text
Journal Article -
11
Retinopatía asociada al cáncer: Fotofobia intensa en paciente con cáncer de mama metastásico
Published in Clinical & translational oncology (01-05-2004)Get full text
Journal Article -
12
Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer
Published in Future Oncology (01-03-2016)“…Nonadvanced non-small-cell lung cancer (NSCLC) has a poor long-term survival from surgery or definitive radiation that is minimally improved with…”
Get full text
Journal Article Book Review -
13
PD-(L)1 inhibitors as monotherapy for the first-line treatment of non-small cell lung cancer patients with high PD-L1 expression: A network meta-analysis
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 9076 Background: PD-L1 has emerged as a potential biomarker for predicting responses to immunotherapy and as a prognostic factor in non-small…”
Get full text
Journal Article -
14
Human Papillomavirus in Non-Small-Cell Lung Cancer: The Impact of EGFR Mutations and the Response to Erlotinib
Published in Archivos de bronconeumología (English ed.) (01-02-2013)“…Abstract It has been suggested that human papillomavirus (HPV) could participate in the development of non-small-cell lung cancer (NSCLC). A higher HPV…”
Get full text
Journal Article -
15
Age does not worsen the efficacy nor tolerance to combined induction therapies in locally advanced non-small cell lung cancer
Published in Anticancer research (01-08-2014)“…One third of non-small cell lung cancer (NSCLC) affects elderly patients in a locally advanced (LA) stage. Induction therapy followed by a curative approach is…”
Get full text
Journal Article -
16
-
17
Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy
Published in Clinical & translational oncology (01-12-2012)“…The gamma-delta (γδ) T-cells are a subset of T-lymphocytes characterized by the presence of a surface antigen recognition complex type 2. Those γδ T-cells…”
Get full text
Journal Article -
18
Little things make big things happen: angiolymphatic invasion and tumor necrosis prognosticate the outcome of locally advanced non-small cell lung cancer treated with a prior induction therapy
Published in American journal of clinical pathology (01-06-2015)“…Size, invasion of thoracic structures, and ipsilateral mediastinal lymph node involvement (pN2) are well-known prognostic factors that configure the staging of…”
Get full text
Journal Article -
19
Little Things Make Big Things Happen
Published in American journal of clinical pathology (01-06-2015)“…Objectives: Size, invasion of thoracic structures, and ipsilateral mediastinal lymph node involvement (pN2) are well-known prognostic factors that configure…”
Get full text
Journal Article -
20
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
Published in Journal of clinical medicine (26-03-2021)“…Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selection of patients more likely to respond to immunotherapy and as a…”
Get full text
Journal Article